The 1st Leeds Precision Oncology Symposium: Developing the pipeline to clinical adoption and impact, Oct. 2016, UK

The inaugural Leeds Precision Oncology Symposium, which will outline the precision oncology pipeline, will take place on Wednesday, 19 October 2016 from 09:00 to 17:30 (BST).

Oncology is at the forefront of precision medicine. Stratified approaches to anti-cancer therapy are generating significant excitement amongst patients and researchers, stirred by evolving partnerships between industry, academia and the National Institute for Health Research (NHS).

Established by the National Institute for Health Research Diagnostic Evidence Co-operative Leeds (NIHR DEC Leeds) and the Leeds Centre for Personalised Medicine and Health, the inaugural Leeds Precision Oncology Symposium will outline the precision oncology pipeline formed by these partnerships and the evolving role of health informatics in supporting the evaluation of new precision oncology technologies. Key opinion leaders from industry and academia will be joined by health economists and representatives from both the NHS and National Institute for Health and Care Excellence (NICE) to address the challenges faced in the later evaluation, commissioning and adoption of new precision cancer treatments.

PLEASE NOTE: This event is free to attend, but due to limited space anyone who doesn’t attend without informing the organisers 48 hours in advance will be charged £50.00.

Further details and registration available here.